The Michigan Institute for Data Science (MIDAS) Fellowship Application
The Michigan Institute for Data Science (MIDAS) is seeking applications for a new AI in Science Postdoctoral Fellowship Program at the University of Michigan (the Schmidt AI in Science program). Funding for the program comes from the Eric & Wendy Schmidt Postdoctoral Fellowship, a program of Schmidt Futures. This program provides outstanding early-career researchers with intensive training & research experience as they ready themselves for independent research in academic & other sectors. We aim to enable the substantive us of AI for breakthroughs in science & engineering, & cultivate global science leaders. Specifically, we will:
1) Catalyze creative & transformative applications of AI with the potential to lead to major scientific breakthroughs carried out by the Fellows and their mentors.
2) Enable a broader U-M research community to adopt AI in imagining, planning, executing, & supporting research applications across a range of science & engineering domains.
3) Provide outstanding training to the Fellows.
4) Collaborate with other sites to maximize the impact of the program.
June 20, 2022
The SCSAP and Jumpcode Grant Challenge
This challenge is open to all UM Researchers and UM SCSAP Members.
Submission Deadline: July 22, 2022
If you’re planning on running 10x Genomic services like Chromium or Visium, we have an award opportunity to incorporate a new technology that enhances gene and UMI detection by up to 50%. Our CRISPRclean Single Cell RNA Boost Kit removes overabundant, non-informational nucleic acids to improve representation of important sequences. LEARN MORE
March 23, 2022
In conjunction with BRCF’s Advanced Genomics Core and NanoString’s upcoming schedule of events, NanoString is also offering a grant program to quantitatively map the whole transcriptome to user-defined regions of FFPE/fresh-frozen tissue using the GeoMx Digital Spatial Profiler.
NanoString’s GeoMx Human Whole Transcriptome Atlas (GeoMx Hu WTA) provides an unbiased view of 18,000+ protein-coding genes. The GeoMx Hu WTA unlocks new pathways to be explored by researchers and enables GeoMx RNA profiling in oncology, immunology, neuroscience, developmental biology, and other diverse fields. GeoMx Hu WTA provides robust and sensitive performance on FFPE or Fresh Frozen samples. LEARN MORE
Grant Deadline: April 22, 2022
The National Cancer Institute (NCI) seeking input on the utility and future promise of multidimensional tumor atlases
NOT-CA-23-011 Request for Information on Challenges and Opportunities Associated with Multidimensional Tumor Atlases
At this time NCI is soliciting feedback on the utility and future promise of multidimensional tumor atlases. All stakeholders with an interest in using or constructing multidimensional tumor atlases are invited to provide information. Note: for the purposes of this request, multidimensional tumor atlases are envisioned to include detailed information at the clinical, tissue, cellular, molecular, morphological, functional, temporal, and/or spatial level.
NCI is particularly interested in hearing from the cancer biology, prevention, and translational cancer research communities, especially those who would like to incorporate knowledge derived from multidimensional tumor atlases. Information about other atlas programs (national or international) that inform responses to the questions above is also welcome. If desired, your response may mention your membership or affiliation within industry, government, or academia.
DEADLINE: 11:59:59 pm (EST) on 01/07/23
Pfizer is seeking proposals for the advancement of RNA therapeutics and the development of the next generation of RNA medicines
Taubman Institute Innovation ProgramThe Taubman Institute is seeking to support new or existing teams of scientists to develop novel and impactful approaches to integrate their research programs into the clinic setting. The goal is to perform systematic, multiscale phenotyping to gain insights into individual variation in the susceptibility, progression, course, or outcomes of disease. The institute will partner with investigators to support the development and implementation of their research programs.
Letter of Intent: Thursday, June 30, 2022
The Lurie Prize in Biomedical Sciences is an award presented by the Foundation for the National Institutes of Health to recognize outstanding achievement by a promising young scientist in biomedical research. The Prize is made possible by a generous gift from philanthropist Ann Lurie.
Deadline: September 20, 2022